Partell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
Partell Specialty Pharmacy is recalling Testosterone 40 mg pellets in Nevada due to a non-approved sterilization method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric for significant injury or property damage reports or high-risk conditions.
Plain-English summary
Partell Specialty Pharmacy is recalling Testosterone 40 mg pellets packaged in amber vials. The recall is being conducted because the firm used a non-approved method of sterilization, resulting in a lack of assurance of sterility for the drug products.
The affected products are prescription-only and were distributed only in Nevada. Specific lot numbers and best-use dates are listed in the recall documentation, including lots 20171214@90, 20171113@81, and 20180220@58.
Consumers who have these products should stop using them and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Testosterone 40 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
- Manufacturer
- Partell Specialty Pharmacy
- Category
- Drug — Injectable Sterile
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: 20171214@90
- BUD 06/12/2018
- 20171113@81
- BUD 05/12/2018
- 20180220@58
- BUD 08/19/2018.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls CoEnzymeQ10 Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereFDA Recalls Testosterone Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-04
- SevereTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Sterile Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23